Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,836	1,435	1,736	1,801	1,959	2,121
Short-Term Investments	293.69	174.26	159.52	70.8	80.8	201.8
Cash & Short-Term Investments	2,130	1,609	1,896	1,872	2,040	2,323
Cash Growth	35.18%	-15.10%	1.27%	-8.25%	-12.19%	26.68%
Accounts Receivable	766.93	847.2	783.01	730.48	580.03	524.06
Other Receivables	17	21.44	26.94	27.66	33.53	18.17
Receivables	783.93	868.64	809.94	758.15	613.55	542.23
Inventory	1,219	1,065	1,147	1,304	1,082	1,350
Prepaid Expenses	175.87	137.26	118.23	162.21	136.07	87.96
Other Current Assets	39.15	295.84	257.28	88.62	53.63	13.89
Total Current Assets	4,347	3,976	4,228	4,185	3,925	4,317
Property, Plant & Equipment	3,853	3,851	3,986	4,019	4,181	2,894
Long-Term Investments	2,629	2,296	1,064	533.57	416.83	191.06
Other Intangible Assets	38.49	43.76	42.69	43.01	78.16	104.48
Long-Term Deferred Tax Assets	585.57	623.1	677.16	588.05	631.87	522.46
Other Long-Term Assets	761.21	780.13	814.28	1,062	170.82	130.57
Total Assets	12,215	11,570	10,812	10,430	9,403	8,160
Accounts Payable	373.62	176.13	348.07	552.2	159.81	318.76
Accrued Expenses	-	296.94	274.85	353.04	390.66	456.17
Short-Term Debt	1,596	2,112	2,324	2,191	2,050	1,225
Current Portion of Long-Term Debt	-	379.89	272.31	350.18	246.82	158.57
Current Portion of Leases	33.05	38.79	41.95	44.06	25.78	32.41
Current Income Taxes Payable	113.37	20.21	138.39	16.02	55.52	13.76
Other Current Liabilities	1,009	283.6	312.65	286.42	303.12	224.54
Total Current Liabilities	3,125	3,308	3,712	3,793	3,232	2,429
Long-Term Debt	1,203	1,343	1,790	1,991	1,680	758.28
Long-Term Leases	326.05	354.37	412.89	447.92	218.46	229.47
Long-Term Deferred Tax Liabilities	615.74	670.13	651.99	671.26	728.29	746.01
Other Long-Term Liabilities	67.7	22.9	23.44	23.3	24.65	26.83
Total Liabilities	5,337	5,746	6,649	6,987	5,950	4,255
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	271.26	271.26	271.26	271.26	263.44	260.77
Retained Earnings	3,324	2,046	1,752	1,738	2,118	2,274
Comprehensive Income & Other	1,738	1,979	624.12	51.9	-307.04	-193.43
Total Common Equity	6,200	5,164	3,514	2,929	2,942	3,209
Minority Interest	677.67	660.39	648	514.77	511.39	696.34
Shareholders' Equity	6,878	5,824	4,162	3,444	3,453	3,905
Total Liabilities & Equity	12,215	11,570	10,812	10,430	9,403	8,160
Total Debt	3,157	4,229	4,841	5,024	4,221	2,403
Net Cash (Debt)	-1,028	-2,620	-2,946	-3,153	-2,181	-80.19
Net Cash Per Share	-11.85	-30.20	-33.88	-36.34	-25.08	-0.92
Filing Date Shares Outstanding	86.26	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.26	86.75	86.75	86.75	86.75	86.75
Working Capital	1,223	667.71	515.42	391.79	693.29	1,888
Book Value Per Share	71.88	59.53	40.51	33.76	33.91	36.99
Tangible Book Value	6,162	5,120	3,472	2,886	2,864	3,104
Tangible Book Value Per Share	71.43	59.03	40.02	33.27	33.01	35.78
Land	-	1,157	1,169	1,169	1,462	578.12
Buildings	-	2,300	2,347	2,243	2,190	1,754
Machinery	-	1,083	1,069	992.9	965.5	918.07
Construction In Progress	-	27.78	3.55	36.12	48.41	0.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.